InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: biosectinvestor post# 358164

Friday, 02/26/2021 4:51:27 PM

Friday, February 26, 2021 4:51:27 PM

Post# of 702047
Look into CYDY. Talking to FDA currently after unblinding their ph 3 trial with severe to critical patients. Quite possibly the first and only drug that would get approved for severe to critical patients. FDA will likely provide EUA mid to end of March. OLE and CPT codes already in place in the US and UK. As NWBO, strong support from KOL scientists with real world patient experience.

Plus they have already met primary endpoints for HIV treatment too, which is a massive market opportunity. Could generate a ton of media attention upon COVID EUA. Also starting a trial with COViD long haulers, which is now recognized by Fauci and others as a real problem they need to tackle.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News